PM Modi sleeps for only 2 hours every day, claims Maharashtra BJP chief
Patil said that Modi is trying to prevent sleep so that he can stay awake for 24 hours and work for the country.
Related Articles
Erythrocyte hemighosts: a hallmark of severe oxidative injury in vivo – PubMed
Erythrocyte hemighosts and ghosts were found in five patients: two with severe oxidant haemolysis caused by chemicals or drugs, and three G6PD deficient subjects with…
Images from the Haematologica Atlas of Hematologic Cytology: parvovirus-induced pure red cell aplasia
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization To create an adaptation, translation,…
Cutting-edge CAR-T cancer therapy is now made in India โ at one-tenth the cost
Nature – The treatment, called NexCAR19, raises hopes that this transformative class of medicine will become more readily available in low- and middle-income countries.
Cutting-edge CAR-T cancer therapy is now made in India โ at one-tenth the cost
Nature – The treatment, called NexCAR19, raises hopes that this transformative class of medicine will become more readily available in low- and middle-income countries.
The three-dimensional porous mesh structure of Cu-based metal-organic-framework – aramid cellulose separator enhances the electrochemical performance of lithium metal anode batteries
Lithium metal, due to its advantages of high theoretical capacity, low density and low electrochemical reaction potential, is used as a negative electโฆ
Supreme Court urges Centre to take call on standard hospital charges or face implementation of CGHS rates | India News – Times of India
India News: The Supreme Court has urged the Centre to take a decision on standard hospital charges or face the implementation of CGHS rates. The…
These are the 10 best hospitals in the world
Newsweek and Statista unveil the world’s best 10 hospitals, spotlighting their care, research and innovation.
Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults
Nature Medicine – Analysis of a European cohort estimated that 1โ2 per 10,000 children, adolescents and young adults are expected to develop a hematological malignancy…
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with EpsteinโBarr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial
Tabelecleucel provides clinical benefit in patients with relapsed or refractory EBV-positive post-transplant lymphoproliferative disease, for whom there are no other approved therapies, without evidence of…